Phase II study of fazarabine in advanced head and neck cancer. A Southwest Oncology Group study.

Suppr

超能文献

作者信息

Kuebler J P, Metch B, Schuller D E, Keppen M, Hynes H E

机构信息

University of Oklahoma Health Center, Oklahoma City.

出版信息

Invest New Drugs. 1991 Nov;9(4):373-4. doi: 10.1007/BF00183585.

DOI:10.1007/BF00183585

PMID:1725172

Abstract

摘要

相似文献

Phase II study of fazarabine in advanced head and neck cancer. A Southwest Oncology Group study.

Invest New Drugs. 1991 Nov;9(4):373-4. doi: 10.1007/BF00183585.

A phase II evaluation of fazarabine in high-grade gliomas: a Southwest Oncology Group study.

Cancer Chemother Pharmacol. 1994;34(2):179-80. doi: 10.1007/BF00685938.

A phase II study of fazarabine in patients with advanced ovarian cancer. A Gynecologic Oncology Group study.

Am J Clin Oncol. 1995 Apr;18(2):156-7. doi: 10.1097/00000421-199504000-00012.

Phase I trial of a 72-h continuous-infusion schedule of fazarabine.

Cancer Chemother Pharmacol. 1992;30(4):321-4. doi: 10.1007/BF00686303.

Phase II trial and cost analysis of fazarabine in advanced non-small cell carcinoma of the lung: a Southwest Oncology Group study.

Invest New Drugs. 1995;13(1):67-71. doi: 10.1007/BF02614223.

Phase II study of fazarabine (NSC 281272) in patients with metastatic colon cancer.

Invest New Drugs. 1993 Feb;11(1):71-4. doi: 10.1007/BF00873915.

Phase II study of 5-aza-2'-deoxycytidine in advanced ovarian carcinoma. The EORTC Early Clinical Trials Group.

Eur J Cancer. 1990 Feb;26(2):137-8. doi: 10.1016/0277-5379(90)90295-5.

Phase I and pharmacokinetic study of arabinofuranosyl-5-azacytosine (fazarabine, NSC 281272).

Cancer Res. 1990 Feb 15;50(4):1220-5.

A phase II study of fazarabine (NSC 281272) in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.

Am J Clin Oncol. 1995 Oct;18(5):439-40. doi: 10.1097/00000421-199510000-00016.

Phase I trial and pharmacokinetic evaluation of fazarabine in children.

Cancer Res. 1989 Sep 15;49(18):5213-6.

引用本文的文献

A phase I trial of fazarabine in refractory pediatric solid tumors. A Pediatric Oncology Group study.

Invest New Drugs. 1993 Nov;11(4):309-12. doi: 10.1007/BF00874429.

本文引用的文献

1-beta-D-arabinosyl-5-azacytosine. Cytocidal activity and effects on the synthesis and methylation of DNA in human colon carcinoma cells.

Mol Pharmacol. 1984 Sep;26(2):381-7.

Mechanism of action of 1-beta-D-arabinofuranosyl-5-azacytosine and its effects in L1210 mouse leukemia cells.

Neoplasma. 1986;33(1):3-10.

Comparison of the activity of arabinosyl-5-azacytosine, arabinosyl cytosine, and 5-azacytidine against intracerebrally implanted L1210 leukemia.

Invest New Drugs. 1985;3(4):331-4. doi: 10.1007/BF00170754.

Arabinofuranosyl-5-azacytosine: antitumor and cytotoxic properties.

Cancer Res. 1986 Feb;46(2):831-8.

Metabolism of 1-beta-D-arabinofuranosyl-5-azacytosine and incorporation into DNA of human T-lymphoblastic cells (Molt-4).

Cancer Res. 1985 Aug;45(8):3522-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验